Trend-Following Backtester · Guide · backtest 한국어

equity · US

Rigel Pharmaceuticals, Inc. backtest

10 trend-following strategies were compared on the full daily history of Rigel Pharmaceuticals, Inc.. 10 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is 볼린저 밴드 돌파 (CAGR 4.3%, MDD -74.0%).

Data 2000-11-29 ~ 2026-07-31daily bars 6,454 (25.7 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -10.5%, drawdown -99.4%).

Sharpe leader (same as main): Supertrend — CAGR 5.8%, MDD -87.0%, Sharpe 0.33, 47% exposure.

Return/drawdown alternative: 볼린저 밴드 돌파 — CAGR is 16.3%p higher than buy and hold, while drawdown improves by 12.4%p (CAGR 4.3%, MDD -74.0%, exposure 26%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=19, mult=2.3
5.8%-87.0%0.330.074.2x21647%
Donchian 채널 돌파
entryN=9, exitN=20
1.0%-92.1%0.300.011.3x19764%
볼린저 밴드 돌파
n=25, k=2.1
4.3%-74.0%0.290.062.9x16426%
MACD
fast=15, slow=53, signal=13
-0.2%-94.2%0.27-0.001.0x33051%
Parabolic SAR
step=0.015, maxStep=0.12
-0.5%-97.1%0.25-0.010.9x41844%
ADX / DI 방향성
period=6, threshold=33
-2.4%-92.8%0.18-0.030.5x48229%
ROC 모멘텀
n=14, threshold=0.11
-2.3%-90.7%0.16-0.030.5x49621%
Keltner 채널 돌파
emaPeriod=26, atrPeriod=24, mult=2.1
-1.4%-81.8%0.12-0.020.7x12422%
EMA 크로스오버
fast=8, slow=28
-8.2%-98.1%0.07-0.080.1x26144%
SMA 크로스오버
fast=15, slow=18
-10.1%-99.1%0.04-0.100.1x50046%
Buy and hold-10.5%-99.4%0.26-0.110.1x1100%
0.1 1x 2001 2005 2009 2013 2017 2021 2025 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -50% -75% -99% 2001 2005 2009 2013 2017 2021 2025 Buy and holdSupertrend
Supertrend maximum drawdown -87.0% (2009-07-21 → 2020-05-14), recovered after 5,964 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next